Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of injectable mouse nerve growth factor for diabetic foot ulcers
ChiCTR1800016368Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of mouse nerve growth factor in diabetic foot ulcer (DFU) (4 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Percentage of complete wound healing. Started Jan 2018; status: recruiting.
02
Drugs
mouse nerve growth factor
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on ChiCTR1800016368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016368.